References
- Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. GMT Opin Immunol 1999;11:648–56.
- Contractor N, Bassiri H, Reya T, Park A, Baumgart D, Wasik M, et al. Lymphoid hyperplasia, autoimmunity, and compro-mised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J Immunol 1998; 160:385–94.
- Sellon R, Tonkonogy S, Schultz M, Duielemann L, Grenther W, Balish E, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activa-tion in interleukin-10-deficient mice. Infect Immun 1998;66: 5224–31.
- Duchmann R, May E, Heike M, Knolle P, Neurath M, Meyer zum Buschenfelde K. T cell specificity and cross reactivity towards enterobacteria, bacteriodes, bifidobacterium, and anti-gens from resident intestinal flora in humans. Gut 1999;44:812–8.
- Cho J. Update on inflammatory bowel genetics. Current Gastroenterol Rep 2000;2:434–9.
- Neurath MF, Fuss I, Kelsall BL, &Ether E, Strober W. Antibodies to interleukin 12 abrogate established colitis in Mice. J Exp Med 1995;182: 1281–90.
- Strober W, Kelsall B, Marth T. Oral tolerance. J Clin Immunol 1998;18:1–30.
- Wirtz S, Finotto S, Kanzler S, Lohse A, Blessing M, Lehr H, et al. Chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF-plus IFN-y-producing CD4+ T cells that respond to bacterial anti-gens. J Immunol 1999;162:1884–8.
- Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller V. IL-10 deficient mice develop chronic enteritis. Cell 1993;75: 263–74.
- Gorelik L, Flavell RA. Abrogation of TGF beta signaling in T cells leads to spontaneous T cell differentiation and autoimmu-nity. Immunity 2000;12:171–81.
- Powrie F, Correa-Oliveiria R, Mauze S, Coffman L. Regulatory interactions between CD45Rbhigh and CD45Rbl0w CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994;179:589–600.
- Fuss I, Marth T, Neurath M, Pearlstein G, Jain A, Strober W. Anti-interleukin-12 treatment regulates apoptosis of T helper 1 T cells in experimental colitis. Gastroenterology 1999;117:1078–88.
- Boirivant M, Fuss I, Ferroni L, De Pascale M, Strober W. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis. J Immunol 2001;166: 3522–32.
- Neurath M, Fuss I, Kelsall B, Presky D, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-y-mediated oral tolerance. J Exp Med 1996; 183:2605–16.
- Kitani A, Fuss I, Nakamura K, Schwartz 0, Usui T, Strober W. Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-betal plasmid: TGF-beta 1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J Exp Med 2000;192: 41–52.
- Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries J, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevent colitis. Nature 1997;389:737–42.
- Asseman C, Smita M, Leach M, Coffman R, Powrie F. An essential role for interleukin-10 in the function of regulatory T cells which inhibit intestinal inflammation. J Exp Med 1999;190: 995–1003.
- Powrie F, Carlino J, Leach M, Mauze, Coffman R. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45Rbl0w CD4+ cells. J Exp Med 1996;183: 2669–74.
- Cua DJ, Hutchins B, LaFace DM, Stohlman SA, Coffman RL. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J Immunol 2001;166: 602–8.